Biotechnology - Pharmaceutical, Markets & Marketing


Popular Filters

1 to 25 of 129 results

Report: IPOs and government support can boost the Australian life sciences industry

Report: IPOs and government support can boost the Australian life sciences industry


Despite a relatively flat December quarter for the PricewaterhouseCoopers Life Sciences Index, it was…

AustraliaBiotechnologyCSL LimitedFinancialMarkets & MarketingPharmaceutical

Survey: Pharma CEOs on the importance of technology, demographics and innovation

Survey: Pharma CEOs on the importance of technology, demographics and innovation


A global survey of chief executives has revealed the priorities and concerns of pharmaceutical and life…

BiotechnologyBoardroomGlobalMarkets & MarketingPharmaceutical

Modest growth forecast for global Crohn’s disease market

Modest growth forecast for global Crohn’s disease market


The global Crohn’s disease (CD) market value is forecast to show modest growth, climbing from $3.2…

AbbVieBiotechnologyEntyvioGastro-intestinalsGlobalHumiraJohnson & JohnsonMarkets & MarketingPharmaceuticalRemicadeStelara InjectionTakeda Pharmaceuticals

Emerging markets and patent cliffs create supply chain management issues for pharma, white paper warns

Emerging markets and patent cliffs create supply chain management issues for pharma, white paper warns


A new white paper commissioned by logistics company DHL warns that global life sciences and health care…

BiotechnologyGlobalMarkets & MarketingPharmaceuticalProduction

What does the future hold for pharma?

What does the future hold for pharma?


Here's our take on the week's top stories.

AstraZenecaBayerBiotechnologyCerulean PharmaMarkets & MarketingPharmaceuticalResearchSanofi

Report: M&A worth $11 billion in third quarter while Russian market shows promise

Report: M&A worth $11 billion in third quarter while Russian market shows promise


PricewaterhouseCoopers (PwC) has released its quarterly Life Sciences Deals Insights Quarterly for the…

BiotechnologyEuropeMarkets & MarketingMergers & AcquisitionsPharmaceutical

Nanomedicine market to increase at a CAGR of 12.6%


The global nanomedicine market has been forecast to increase at a compound annual growth rate (CAGR)…

BiotechnologyGlobalMarkets & MarketingPharmaceutical

New therapies to spur acute myeloid leukemia market growth


Driven by a boost in new therapies entering the market, as well as an increasing number of acute myeloid…

BiotechnologyCyclacel PharmaceuticalsMarkets & MarketingmidostaurinNovartisOncologyPharmaceuticalsapacitabineSunesis Pharmaceuticalsvosaroxin

Eylea captures quarter of wet-AMD patient share in USA, surpassing Lucentis


Retinal specialists/general ophthalmologists in the USA surveyed by BioTrends Research, a unit of health…

BiotechnologyMarkets & MarketingNorth AmericaOphthalmicsPharmaceutical

Cancer drug sales reps find access to oncologist most restricted


Oncology remains the most restrictive specialty for pharmaceutical sales representative access this year…

BiotechnologyMarkets & MarketingNorth AmericaOncologyPharmaceutical

New entrants to multiple sclerosis market will drive 10% pa growth through 2018


The market for disease-modifying multiple sclerosis (MS) therapies will expand at an annual rate of 10%…

AbbVieAubagioBayerBiogen IdecBiotechnologydaclizumabGlobalLemtradaMarkets & MarketingNeurologicalocrelizumabPharmaceuticalRocheSanofiTecfidera

Strong uptake of Regeneron/Bayer wet AMD drug Eylea in USA, but Avastin still leads


The majority of wet age-related macular degeneration (AMD) patients are administered their first intravitreal…

AllerganAvastinBayerBiotechnologyEyleaFovistaLucentisMarkets & MarketingNorth AmericaOphthalmicsOphthotechPharmaceuticalRegeneronRoche

Oncologists positive on Tafinlar, Mekinist and nivolumab for unresectable malignant melanoma


US and European oncologists surveyed by health care advisory firm Decision Resources indicate that overall…

BiotechnologyBristol-Myers SquibbEuropeGlaxoSmithKlineMarkets & MarketingMekinistnivolumabNorth AmericaOncologyPharmaceuticalRocheTafinlarZelboraf

Pivotal drivers for prescribing metastatic pancreatic cancer drugs: report


The effect on key efficacy endpoints, primarily the effect of an emerging therapy on overall survival,…

AbraxaneBiotechnologyCelgeneEli LillyEuropeGemzarMarkets & MarketingNorth AmericaOncologyOnconova TherapeuticsPharmaceuticalrigosertib

EFPIA releases code on financial relations with health care professionals


The European Federation of Pharmaceutical Industries and Associations (EFPIA) has released its disclosure…

BiotechnologyEuropeFinancialMarkets & MarketingPharmaceuticalRegulation

Oncologists favor Avastin as first-line therapy for metastatic colorectal cancer


For the treatment of metastatic colorectal cancer (mCRC), a majority of surveyed US oncologists surveyed…

AvastinBayerBiotechnologyBristol-Myers SquibbErbituxMarkets & MarketingMerck SeronoNorth AmericaOncologyPharmaceuticalRegeneronRocheSanofiStivargaZaltrap

Rise of rheumatoid arthritis therapies: JAK inhibitor battle and biosimilar threats


An approval of US drug major Eli Lilly (NYSE: LLY) and Incyte Pharmaceuticals'(Nasdaq: INCY) drug baricitinib…

Anti-Arthritics/RheumaticsbaricitinibBiotechnologyEli LillyIncyteMarkets & MarketingPfizerPharmaceuticalPricingXeljanz

Lupus therapeutics boast blockbuster hopefuls as R&D continues, says GlobalData


Lupus therapeutics are lacking, and patients with moderate forms of the disease are greatly underserved,…

BenlystaBiotechnologyBristol-Myers SquibbepratuzumabGlaxoSmithKlineImmunologicalsMarkets & MarketingOrenciaPharmaceuticalRare diseasesResearchUCB

Turkey's NSCLC drug market forecast to expand at 7% a year through 2017


From 2012 to 2017, the non-small-cell lung cancer (NSCLC) market in Turkey will increase at an annual…

AlimtaBiotechnologyEli LillyEuropeMarkets & MarketingOncologyPharmaceuticalRocheTarceva

Emerging targeted therapies offer advantages over currently-used platinum-resistant ovarian cancer drugs


The effect of an emerging therapy on key efficacy endpoints, including time to disease progression and…

AmgenAstraZenecaAvastinBiotechnologyMarkets & MarketingMerck & CoNorth AmericaolaparibOncologyPharmaceuticalRochetrebananibvintafolide

Government programs play huge role in growth of Turkey's health care market; F&S report


Government funding, growth and consolidation of the middle class, and the rise in non-communicable diseases…

BiotechnologyEuropeHealthcareMarkets & MarketingPharmaceuticalPolitics

AbbVie/Eisai's Humira has best clinical profile among psoriatic arthritis treatments


Based on clinical data and the opinions of interviewed thought leaders interviewed by health care advisory…

AbbVieAnti-Arthritics/RheumaticsAstellas PharmaBiotechnologyCimziaEisaiEuropeHumiraMarkets & MarketingNorth AmericaPharmaceuticalUCB

1 to 25 of 129 results

Back to top